What is metoprolol succinate?
Metoprolol succinate, commonly known by the brand name Toprol-XL, is a medication used to treat high blood pressure, angina, and certain heart-related conditions. It belongs to a class of drugs called beta blockers, which work by slowing down the heart rate and reducing the heart's workload.
How does metoprolol succinate work?
Metoprolol succinate is a long-acting tablet that is released slowly over a 24-hour period. It is designed to provide a consistent level of beta blockade throughout the day, which can help to lower blood pressure, reduce the frequency and duration of angina attacks, and improve exercise tolerance.
What are the benefits of metoprolol succinate?
According to the [FDA's website][1], the benefits of metoprolol succinate include:
* Lowering blood pressure and reducing the risk of cardiovascular events, such as heart attacks and strokes
* Reducing the frequency and severity of angina attacks
* Improving exercise tolerance and reducing the symptoms of heart failure
* Reducing the risk of death from heart-related causes
Who makes metoprolol succinate?
Metoprolol succinate is manufactured by several pharmaceutical companies, including AstraZeneca (the original developer of the medication) and various generic manufacturers. According to [DrugPatentWatch.com][2], metoprolol succinate is no longer protected by a patent, and several generic versions of the medication are now available.
When does exclusivity expire?
As mentioned earlier, [DrugPatentWatch.com][2] reports that the patent for metoprolol succinate expired several years ago, allowing generic versions of the medication to enter the market.
Can biosimilars enter before patent expiry?
In the US, biosimilars are not subject to the same patent laws as traditional small molecule drugs. However, under the Biologics Price Competition and Innovation Act (BPCIAct) of 2009, biosimilars must show that they are "highly similar" to the original biologic product in order to be approved by the FDA [3].
What side effects are patients asking about?
Common side effects of metoprolol succinate include dizziness, fatigue, weakness, and shortness of breath [4]. According to the FDA, patients should report any concerns or side effects to their healthcare provider promptly.
Why are companies challenging this patent?
It is not uncommon for pharmaceutical companies to challenge patents related to medications, particularly if they believe that the patent was granted in error or if they wish to develop their own versions of the medication. However, without more information, it is difficult to determine why specific companies may be challenging the metoprolol succinate patent.
How does this drug compare with Keytruda?
This section is not applicable, as metoprolol succinate and Keytruda (pembrolizumab) are two entirely different medications used to treat different conditions.
What happens if I stop taking metoprolol succinate?
Stopping metoprolol succinate abruptly can lead to rebound hypertension, which can increase the risk of heart-related events [5]. Patients should consult their healthcare provider before making any changes to their medication regimen.
Sources:
[1] FDA: Toprol-XL (metoprolol succinate) (https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/toprol-xl-metoprolol-succinate)
[2] DrugPatentWatch.com: Metoprolol succinate (https://www.drugpatentwatch.com/drug/metoprolol-succinate)
[3] FDA: Biosimilars (https://www.fda.gov/drugs/biosimilars/biosimilars)
[4] MedlinePlus: Metoprolol (https://medlineplus.gov/druginfo/meds/a682472.html)
[5] MedlinePlus: Metoprolol (https://medlineplus.gov/druginfo/meds/a682472.html)